Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
New diagnostic could improve outcomes for oesophageal cancer A team of The University of Queensland’s Frazer Institute scientists and clinicians based at the Translational Research Institute (...Read more
International Clinical Trials Day: Q and A with TRI’s Steve Turner On International Clinical Trials Day on 20 May, we honour the incredibly hardworking professionals in the clinical trials...Read more
Mathematics maps lifecycle of melanoma in new biotech experiments TRI-based QUT and UQDI researchers, including Gency Gunasingh and Nikolas Haass, are part of a team leading the world in new...Read more
Advancing cancer immunotherapies to save more lives: Meet The University of Queensland Diamantina Institute’s TRI-based cancer immunologist Dr Janin Chandra This World Health Day’s theme...Read more
Better patient outcomes the focus of new LINC grants Translational Research Institute (TRI), Metro South Health (MSH) and Mater Research, have announced the recipients of almost $400,000 in new...Read more
A woman on a mission: Dr Blerida Banushi Dr Blerida Banushi has fit more in a lifetime than most: fighting cancer in a TRI lab at UQDI before scaling the sky became her next frontier. Always...Read more
New treatments for advanced prostate cancer QUT’s Dr Lisa Philp is combining her knowledge of hormones and metabolism to develop a new treatment for late stage prostate cancer . Based at TRI...Read more
Anti-androgen therapy may fuel spread of bone tumours in advanced prostate cancer Anti-androgen therapy is commonly used to treat patients with advanced prostate cancer which has spread to the bones...Read more
Immune cells Found to attack melanoma Researchers investigating a recently discovered type of immune cells have discovered they can halt the rapid development of melanoma lesions. A TRI-based team...Read more
Artificial intelligence opening new fields for cancer researchers Genomic researchers at the Translational Research Institute are using artificial intelligence (AI) to discover potential new...Read more